Needham & Company LLC Reiterates “Buy” Rating for Evolent Health (NYSE:EVH)
Evolent Health (NYSE:EVH – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at Needham & Company LLC in a note issued to investors on Wednesday,Benzinga reports. They presently have a $15.00 price target on the technology company’s stock. Needham & Company LLC’s price objective suggests a potential upside of 50.66% from the […]
Evolent Health (NYSE:EVH – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at Needham & Company LLC in a note issued to investors on Wednesday,Benzinga reports. They presently have a $15.00 price target on the technology company’s stock. Needham & Company LLC’s price objective suggests a potential upside of 50.66% from the […]
